Prognostic significance of BMP and activin membrane-bound inhibitor in colorectal cancer

Table 3 BAMBI expression in human colorectal carcinomas after curative surgery: Correlations with clinicopathological parameters

		BAMBI expression
		Weak		Strong		P1
		n	%	n	%
Gender	Male	41	26.1	11	7.1
	Female	69	43.9	36	22.9	NS
Age	27-59	60	38.2	24	15.4
	60-95	50	31.8	23	14.6	NS
Location	Right side	37	23.6	12	7.6
	Left side	27	17.2	16	10.2
	Rectum	46	29.3	19	12.1	NS
Tumor size (mm)	≤ 39	50	31.8	19	12.1
	40-59	35	22.3	15	9.6
	≥ 60	25	15.9	13	8.3	NS
Depth of invasion	Tis, T1, T2	38	24.2	9	5.7
	T3, T4	72	45.9	38	24.2	0.054
Histology	G1	36	22.9	9	5.7
	G2	67	42.7	32	20.4
	G3	7	4.5	6	3.8	0.043
LN metastases2	No	59	37.6	22	14.0
	Yes	51	32.5	25	15.9	NS
TNM stage	I	33	21.0	7	4.5
	II	35	22.3	16	10.2
	III	35	22.3	18	11.4
	IV	7	4.5	6	3.8	0.035
Metastatic site
Liver	No	2	28.6	5	83.3
	Yes	5	71.4	1	16.7	NS
Lung	No	6	85.7	6	100
	Yes	1	14.3	0	0	NS
Distant lymph nodes	No	7	100	6	100
	Yes	0	0	0	0	NS

¹Kruskal-Wallis or Mann-Whitney test; P < 0.05 was considered statistically significant;

²Lymph node (LN) metastases. NS: Not significant.